MOH — authorised 4 September 2014
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
🇮🇱 Keytruda in Israel
MOH authorised Keytruda on 4 September 2014
Marketing authorisations
MOH — authorised 28 April 2020
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
MOH — authorised 21 November 2025
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
Keytruda in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Keytruda approved in Israel?
Yes. MOH authorised it on 4 September 2014; MOH authorised it on 28 April 2020; MOH authorised it on 21 November 2025.
Who is the marketing authorisation holder for Keytruda in Israel?
MERCK SHARP DOHME holds the Israeli marketing authorisation.